[Routine practice data collection for etranacogene dezaparvovec (haemophilia B): Review of the study protocol (Version 2.0) and statistical analysis plan (Version 2.0) – Third addendum to Commission A22-83]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018013132
German
Original Title:
Anwendungsbegleitende Datenerhebung zu Etranacogen Dezaparvovec: Prüfung des Studienprotokolls (Version 3.0) und des statistischen Analyseplans (Version 3.0)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a24-38.html
Year Published:
2024
URL for published report:
https://www.iqwig.de/download/a24-38_etranacogen-dezaparvovec_addendum-zum-projekt-a22-83_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Hemophilia B
- Factor IX
- Genetic Therapy
- Registries
Keywords
- Etranacogene Dezaparvovec
- Hemophilia B
- Benefit Assessment
- Registries
- Research Design
- Peer Review – Research
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.